Literature DB >> 8952541

Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.

I A Lubensky1, J R Gnarra, P Bertheau, M M Walther, W M Linehan, Z Zhuang.   

Abstract

Patients with von Hippel-Lindau (VHL) disease develop a spectrum of bilateral clear-cell renal lesions including cysts and renal cell carcinomas (RCCs). VHL gene deletions have been previously reported in VHL-associated macroscopic RCC. Although histological analysis suggests that microscopic cystic lesions in the VHL patients may represent precursors of the RCC, there is at present no direct molecular evidence of their relationship. To investigate the relationship between cystic lesions and RCC, 26 microdissected archival renal lesions from two VHL disease patients were studied for loss of heterozygosity at the VHL gene locus using polymerase chain reaction single-strand conformation polymorphism analysis. The renal lesions included 2 benign cysts, 5 atypical cysts, 5 microscopic RCCs in situ, 5 cysts lined by a single layer of cells, in which RCCs in situ were developing, and 2 microscopic and 7 macroscopic RCCs. Except for a single benign cyst, 25 of 26 renal lesions showed nonrandom allelic loss of the VHL gene. In either of the 2 patients, the same VHL allele was deleted in all of the lesions tested, indicating loss of the wild-type allele and retention of the inherited, mutated VHL allele. The results suggest that all clear-cell lesions in the VHL kidney represent neoplasms and that the loss of the VHL gene occurs early in their development. Atypical and benign cysts most likely represent the initial phenotype in malignant transformation to the RCC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8952541      PMCID: PMC1865348     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.

Authors:  P Anglard; K Tory; H Brauch; G H Weiss; F Latif; M J Merino; M I Lerman; B Zbar; W M Linehan
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

2.  Specific genetic change in tumors associated with von Hippel-Lindau disease.

Authors:  K Tory; H Brauch; M Linehan; D Barba; E Oldfield; M Filling-Katz; B Seizinger; Y Nakamura; R White; F F Marshall
Journal:  J Natl Cancer Inst       Date:  1989-07-19       Impact factor: 13.506

3.  Simple renal cysts, atypical renal cysts, and renal cell carcinoma in von Hippel-Lindau disease: a lectin and immunohistochemical study in six patients.

Authors:  P J Kragel; M M Walther; J P Pestaner; M R Filling-Katz
Journal:  Mod Pathol       Date:  1991-03       Impact factor: 7.842

4.  Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3.

Authors:  S Hosoe; H Brauch; F Latif; G Glenn; L Daniel; S Bale; P Choyke; M Gorin; E Oldfield; A Berman
Journal:  Genomics       Date:  1990-12       Impact factor: 5.736

5.  Nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease.

Authors:  N Shinohara; K Nonomura; T Harabayashi; M Togashi; S Nagamori; T Koyanagi
Journal:  J Urol       Date:  1995-12       Impact factor: 7.450

6.  Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma.

Authors:  B Zbar; H Brauch; C Talmadge; M Linehan
Journal:  Nature       Date:  1987 Jun 25-Jul 1       Impact factor: 49.962

7.  Renal pathology in von Hippel-Lindau disease.

Authors:  D Solomon; A Schwartz
Journal:  Hum Pathol       Date:  1988-09       Impact factor: 3.466

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

Review 9.  von Hippel-Lindau disease affecting 43 members of a single kindred.

Authors:  J M Lamiell; F G Salazar; Y E Hsia
Journal:  Medicine (Baltimore)       Date:  1989-01       Impact factor: 1.889

10.  The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients.

Authors:  P L Choyke; G M Glenn; M M Walther; B Zbar; G H Weiss; R B Alexander; W S Hayes; J P Long; K N Thakore; W M Linehan
Journal:  AJR Am J Roentgenol       Date:  1992-12       Impact factor: 3.959

View more
  43 in total

Review 1.  Involvement of members of the cadherin superfamily in cancer.

Authors:  Geert Berx; Frans van Roy
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09-23       Impact factor: 10.005

Review 2.  Breaking through a plateau in renal cell carcinoma therapeutics: development and incorporation of biomarkers.

Authors:  Sumanta Kumar Pal; Marcin Kortylewski; Hua Yu; Robert A Figlin
Journal:  Mol Cancer Ther       Date:  2010-11-15       Impact factor: 6.261

Review 3.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

4.  VHL-deficient vasculogenesis in hemangioblastoma.

Authors:  Sven Gläsker; Jonathan Smith; Mark Raffeld; Jie Li; Edward H Oldfield; Alexander O Vortmeyer
Journal:  Exp Mol Pathol       Date:  2014-01-04       Impact factor: 3.362

5.  Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion.

Authors:  Bjoern Buchholz; Gunnar Schley; Diana Faria; Sven Kroening; Carsten Willam; Rainer Schreiber; Bernd Klanke; Nicolai Burzlaff; Jonathan Jantsch; Karl Kunzelmann; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

6.  Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein.

Authors:  S Lee; M Neumann; R Stearman; R Stauber; A Pause; G N Pavlakis; R D Klausner
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 7.  The molecular basis of von Hippel-Lindau disease.

Authors:  O Iliopoulos; W G Kaelin
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

8.  Mechanism of von Hippel-Lindau protein-mediated suppression of nuclear factor kappa B activity.

Authors:  Jiabin An; Matthew B Rettig
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Progression of epididymal maldevelopment into hamartoma-like neoplasia in VHL disease.

Authors:  Gautam U Mehta; Sharon B Shively; Heng Duong; Maxine G B Tran; Travis J Moncrief; Jonathan H Smith; Jie Li; Nancy A Edwards; Russell R Lonser; Zhengping Zhuang; Marsha J Merrill; Mark Raffeld; Patrick H Maxwell; Edward H Oldfield; Alexander O Vortmeyer
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

10.  Renal carcinogenesis in models of diabetes in rats: metabolic changes are closely related to neoplastic development.

Authors:  F Dombrowski; L Klotz; P Bannasch; M Evert
Journal:  Diabetologia       Date:  2007-10-19       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.